Suchergebnisse - "Patel, Nancy"

PubPharm (5)

1

Virologic Efficacy of Casirivimab and Imdevimab COVID-19 Antibody Combination in Outpatients With SARS-CoV-2 Infection : A Phase 2 Dose-Ranging Randomized Clinical Trial

enthalten in: JAMA network open | 2022

von Portal-Celhay, C. | Forleo-Neto, E. | Eagan, W. | +127

2

Effect of Subcutaneous Casirivimab and Imdevimab Antibody Combination vs Placebo on Development of Symptomatic COVID-19 in Early Asymptomatic SARS-CoV-2 Infection : A Randomized Clinical Trial

enthalten in: JAMA | 2022

von O'Brien, M. | Forleo-Neto, E. | Sarkar, N. | +136

UpdateOf: medRxiv. 2021 Sep 18;:. - PMID 34159343

3

REGEN-COV Antibody Combination and Outcomes in Outpatients with Covid-19

enthalten in: The New England journal of medicine | 2021

von Weinreich, D. | Sivapalasingam, S. | Norton, T. | +138

4

Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19

enthalten in: The New England journal of medicine | 2021

von O'Brien, M. | Forleo-Neto, E. | Musser, B. | +134

UpdateOf: medRxiv. 2021 Jun 17;:. - PMID 34159344

5

A CASE IN POINT - Acute hypoxemic respiratory failure as a manifestation of urinothorax - The patient, a 75-year-old man with a history of benign prostatic hypertrophy, presented with shortness of breath, tachypnea, and oliguria. Drs Patel and Allen describe how the diagnosis was established.

enthalten in: The Journal of respiratory diseases | 2007

von Patel, N. | Allen, S.

1
[1]